Semaglutide / Tirzepatide
Also known as Ozempic · Wegovy · Mounjaro · Zepbound
Incretin-class therapies that modulate appetite, slow gastric emptying, and improve insulin response.
Mechanism of action
How Semaglutide / Tirzepatide works
Bind to GLP-1 (and in tirzepatide, GIP) receptors to amplify post-prandial insulin release, slow gastric emptying, and reduce appetite signaling in the central nervous system.
Areas of study
What Semaglutide / Tirzepatide is studied for
- check
Sustainable weight reduction in adults with elevated BMI
- check
Glycemic control in type 2 diabetes
- check
Cardiovascular risk reduction in metabolic syndrome
Considerations
Important things your physician will discuss
This is general clinical context — not medical advice. Your evaluation determines whether Semaglutide / Tirzepatide is appropriate for you.
- info
Contraindicated in patients with personal or family history of medullary thyroid carcinoma or MEN-2
- info
GI side effects (nausea, transient appetite suppression) are common during titration
- info
Not appropriate during pregnancy, breastfeeding, or planned conception
Used in
Protocols that reference Semaglutide / Tirzepatide
Related peptides
More from the Metabolic category
Tesamorelin
Growth-hormone-releasing-hormone analog studied for visceral adipose tissue reduction and body composition shifts.
View peptide arrow_outwardLipolytic GH fragmentAOD-9604
Investigational fragment of human growth hormone studied for fat metabolism without classical GH side effects.
View peptide arrow_outwardCurious whether this peptide fits your protocol?
A licensed Allora physician will review your goals, history, and labs before recommending any therapy.